Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/1998
03/26/1998WO1998000539A3 (mitogen-activated protein kinase) kinase-3 (mkk3) interacting protein (mip)
03/26/1998WO1998000023A3 Plant protection method
03/26/1998WO1997048724A3 Human metabotropic glutamate receptor
03/26/1998WO1997048370A3 Vaccines comprising synthetic genes
03/26/1998WO1997047740A3 VACCINE CONTAINING A PEROXIREDOXIN AND/OR A β-TUBULIN
03/26/1998WO1997045541A3 Patched genes and their uses
03/26/1998WO1997044447A3 Transcriptional activation system, activators, and uses therefor
03/26/1998WO1997040809A3 METHOD OF ENHANCING EFFECT OF NEUROTROPHIN WITH ANALOGUES OF p75NTR367-379
03/26/1998WO1997040162A3 Pesticidal toxins
03/26/1998WO1997040072A3 Adam proteins and uses thereof
03/26/1998WO1997040063A3 Pathogenic escherichia coli associated protein espa
03/26/1998WO1997039030A3 Secreted proteins
03/26/1998WO1997036535A3 Biomarkers for detection, diagnosis and prognosis of prostate cancer
03/26/1998WO1997035990A3 Histone deacetylases, and uses related thereto
03/26/1998DE19723690A1 Use of Fc-gamma receptor antibodies
03/26/1998DE19704301C1 Human endoglin gene promoter
03/26/1998DE19641180A1 Verfahren zur Darstellung von APP-Sekretase Modulation und deren Verwendung als Mittel zur Behandlung der Alzheimer'schen Erkrankung A method for representation of APP-secretase modulation and their use as agents for the treatment of Alzheimer's disease
03/26/1998DE19639346A1 Production of recombinant staphylokinase
03/26/1998CA2269092A1 Rh blood group antigen compositions and methods of use
03/26/1998CA2267343A1 Strain selection of pneumococcal surface proteins
03/26/1998CA2267288A1 Hematopoietic stem cells and methods for generating such cells
03/26/1998CA2266753A1 A method of stable integration of dna into neurons
03/26/1998CA2266656A1 Compositions and methods for treating intracellular diseases
03/26/1998CA2266585A1 Use of leptin antagonists for treating insulin resistance in type ii diabetes
03/26/1998CA2266532A1 Metalocarboxypeptidase inhibitors and derived molecules used as antitumor agents
03/26/1998CA2266428A1 Method to detect dirofilaria immitis infection
03/26/1998CA2266425A1 Human b-cell translocation genes-2 and 3
03/26/1998CA2266410A1 Method of cell surface activation and inhibition
03/26/1998CA2266346A1 Use of proteins as agents against autoimmune diseases
03/26/1998CA2265898A1 Recombinant plant cells expressing heterochromatin 1 (hp1) of drosophila melanogaster
03/26/1998CA2265852A1 Targeting antigens to the mhc class i processing pathway with anthrax toxin fusion protein
03/26/1998CA2265571A1 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof
03/26/1998CA2265518A1 Immunogenic peptides of foot-and-mouth disease viruses
03/26/1998CA2264744A1 Delivery of therapeutic gene products by intestinal cell expression
03/26/1998CA2264542A1 Human gtp binding protein gamma-3
03/26/1998CA2264487A1 Soluble polypeptides with activity of the ns3 serine protease of hepatitis c virus, and process for their preparation and isolation
03/26/1998CA2263821A1 Novel human interferon-inducible protein
03/26/1998CA2263818A1 Novel tumor proteins
03/26/1998CA2236165A1 Novel polypeptide from haemophilus paragallinarum and process for preparing the same
03/25/1998EP0831148A1 Human adhesion molecule occludin
03/25/1998EP0830604A1 Methods and uses for apoptin
03/25/1998EP0830602A1 Expression system for non-secretor genes
03/25/1998EP0830601A1 Use of a phycobiliprotein-binding peptide complex as a fluorescent tracer
03/25/1998EP0830509A1 Polymers responsive to electrical energy
03/25/1998EP0830457A1 Methods for evaluation of antimicrobial targets
03/25/1998EP0830456A1 ISOLATED FrpB NUCLEIC ACID MOLECULE AND VACCINE
03/25/1998EP0830452A1 Immune-evading proteins
03/25/1998EP0830451A1 Plant pathogen resistance genes and uses thereof
03/25/1998EP0830380A1 Antigenic group b streptococcus type ii and type iii polysaccharide fragments having a 2, 5-anhydro-d-mannose terminal structure and conjugate vaccine thereof
03/25/1998EP0830377A1 Glucagon-like peptide-2 and its therapeutic use
03/25/1998EP0830376A1 Process for producing erythropoietin containing no animal proteins
03/25/1998EP0830375A1 Human inhibitor of apoptosis gene 1
03/25/1998EP0830374A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
03/25/1998EP0830373A1 Cd6 ligand
03/25/1998EP0830372A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
03/25/1998EP0830367A1 High-affinity nucleic acid ligands of cytokines
03/25/1998EP0830139A1 Modified myelin protein molecules
03/25/1998EP0830138A1 Use of fibroblast growth factors to stimulate bone growth
03/25/1998EP0830130A1 Tnf-alpha converting enzyme
03/25/1998EP0830062A1 Controlling hemipteran insect pests with bacillus thuringiensis
03/25/1998EP0679094B1 Compounds for targeting
03/25/1998EP0624163B1 Cyclic calcitonin derivatives and method for their production
03/25/1998EP0564531B1 Enrichment method for variant proteins with altered binding properties
03/25/1998EP0461165B2 Yeast processing system comprising a negatively charged amino acid adjacent to the processing site
03/25/1998CN1177377A Prodn. of enzymatically active recombinant carboxypeptidase B
03/25/1998CN1177342A Novel cationic lipids and the use thereof
03/25/1998CN1177302A Lymphotoxin-
03/25/1998CN1177005A Method for gene clone of inhibitory factor for hyperplasia of inner blood vessel cells in human body's real tumor, and using same to anti tumer blood vessel regeneration
03/25/1998CN1037857C Method for preparing peptide derivatives by using black chain mould
03/25/1998CN1037845C Method for preparing stable bioactive somatotropine
03/25/1998CN1037844C Tnf-muteins
03/24/1998US5731490 Mutant mouse lacking the expression of interferon regulatory factor 1 (IRF-1)
03/24/1998US5731428 gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies
03/24/1998US5731427 Nucleic acids encoding a gap-associated protein
03/24/1998US5731425 Synthetic gene
03/24/1998US5731424 High affinity TGFβ nucleic acid ligands and inhibitors
03/24/1998US5731419 Freezing tolerance proteins Wcs19 and Wcor410 from gramineae
03/24/1998US5731418 Flash drying wet, detanned, leather waste; mixed with gelatin; oil absorber
03/24/1998US5731416 Peptide based nucleic acid surrogates
03/24/1998US5731415 Lipopolysaccharide binding protein derivatives
03/24/1998US5731412 Protein, DNA coding for same and method of producing the protein
03/24/1998US5731411 Promotion of homologous DNA pairing by RecA-derived peptides
03/24/1998US5731410 Neurological disorders
03/24/1998US5731409 Polypeptides with type I collagen activity
03/24/1998US5731408 Cyclic heptapeptide
03/24/1998US5731295 Method of reducing stromelysin RNA via ribozymes
03/24/1998US5731288 Compositions containing contortrostatin and methods for the use thereof
03/24/1998US5731284 Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product
03/24/1998US5731200 Isolated nucleic acid encoding receptor-like TGF-β1 binding protein
03/24/1998US5731196 Salmonella virulence genes
03/24/1998US5731195 Specified amino acid sequences
03/24/1998US5731194 Insecticide protein and gene
03/24/1998US5731193 Plasmid vector and an interferon promoter increasing produce gene expressed polypeptide
03/24/1998US5731192 Collagen COL4A6: gene, protein and method of detecting collagen deficiency
03/24/1998US5731190 Penton base protein and methods of using same
03/24/1998US5731188 Vaccine
03/24/1998US5731187 Process for preparing hepatitis A (HAV) antigens and vaccines
03/24/1998US5731170 DNA encoding a growth factor specific for epithelial cells
03/24/1998US5731169 cDNA fragment coding the alpha interferon receptor gene and process for the preparation of a corresponding protein
03/24/1998US5731168 Method for making heteromultimeric polypeptides